1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow Sean Liu: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Live Recombinant Newcastle Disease Virus-vectored COVID-19 Vaccine Phase 1 Study. Sodium Chloride, NDV-HXP-S IN low dose, NDV-HXP-S IM low dose - SARS-CoV-2 | Phase 1 | Completed | Sean Liu | 35 | 2022-02-09 | 2025-04-17 |
COVID-19 (1)
NDV-HXP-S COVID-19 vaccine (1) · Sodium Chloride (1)
United States (1)